Company Presentations
Virtual KOL Event
Featuring Dr. Steven Arnold, Harvard Medical School and Massachusetts General Hospital for a discussion on inflammation and the context for the anticipated Phase 3 topline data readout.
RedChip Money Report®
RedChip’s Money Report, Craig Belsford, interviews BioVie’s President & CEO, Cuong Do
Exclusive Interview • December 16, 2022
Proactive with Steve Darling
Proactive Investors interviews BioVie’s Chief Medical Officer, Dr. Joseph Palumbo
Exclusive Interview • December 12, 2022
Traders News Source Interview
Toni Loudenbeck of Traders News Source interviews BioVie President & CEO, Cuong Do
Exclusive Interview • December 12, 2022
Varney & Co. Welcomes BioVie to NY Studio
Fox Business’s, Varney & Co. Interviews BioVie President & CEO, Cuong Do
Exclusive Interview • December 7, 2022
Proactive with Natalie Stoberman
Proactive Investors interviews BioVie’s President & CEO, Cuong Do to discuss latest AD & PD news
Exclusive Interview • December 6, 2022
Innovators with Jane King
LilaMax Media’s, Jane King interviews BioVie’s President & CEO, Cuong Do at NASDAQ
Exclusive Interview • December 4, 2022
BioVie KOL Webinar
Neuroinflammation and Insulin Resistance and New Treatment Approaches for Alzheimer’s Disease.
Webinar • October 26, 2021
(Requires Login)
American Diabetes Association Thought Leadership Series
Understanding the Links Between Insulin Resistance and Alzheimer’s.
NE3107 Video • June 2021
BioVie KOL Webinar
Advanced Liver Cirrhosis – BIV-201 Phase 2b Clinical Trial Update.
Webinar • November 11, 2021
(Requires Login)